by rafael on Dec 31 2020

-- by Laurie McGinley, The Washington Post:

Medical centers in the United States are balking at providing the only treatment for covid-19 that aims to keep people out of the hospital, leaving hundreds of thousands of doses of the medication unused.

Monoclonal antibodies — described as “unbelievable” by President Trump, who received the treatment this fall — are designed for patients newly diagnosed with covid-19, the disease caused by the coronavirus, who have a high risk of developing complications and becoming seriously ill.

But for hospitals already strained by a surge of covid-19 cases, the outpatient pharmaceutical treatment presents a major logistical challenge as exhausted staff scramble to care for patients and race to inoculate front-line workers with the first coronavirus vaccines.

Read More